[1] TRIMARCHI H, BARRATT J, CATTRAN DC, et al.Oxford classification of IgA nephropathy 2016:an update from the IgA Nephropathy Classification Working Group[J].Kidney Int, 2017, 91(5):1014. doi: 10.1016/j.kint.2017.02.003
[2] YOON CY, CHANG TI, KANG EW, et al.Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy[J].Ann Med, 2017, 49(3):217. doi: 10.1080/07853890.2016.1252058
[3] LIN J, CHENG Z, QIAN Q.Elderly patients with glomerular diseases and IgA nephropathy[J].Nephrology(Carlton), 2017, 22:20.
[4] ROBERT T, BERTHELOT L, CAMBIER A, et al.Molecular insights into the pathogenesis of IgA nephropathy[J].Trends Mol Med, 2015, 21(12):762. doi: 10.1016/j.molmed.2015.10.003
[5] D'AMICO G.Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome[J].Semin Nephrol, 2004, 24(3):179. doi: 10.1016/j.semnephrol.2004.01.001
[6] 靳会欣, 庞国勋, 赵彩霞.雷公藤甲素药理作用及分子水平机制研究进展[J].河北医药, 2017, 39(12):1884. doi: 10.3969/j.issn.1002-7386.2017.12.038
[7] FU Y, LIN Q, GONG T, et al.Renal-targeting triptolide glucosamine conjugate exhibits lower toxicity and superior efficacy in attenuation of ischemia/reperfusion renal injury in rats[J].Acta Pharmacol Sin, 2016, 37(11):1467. doi: 10.1038/aps.2016.44
[8] 范鸿儒, 杨继红, 王萌, 等.雷公藤甲素延缓糖尿病肾病进展的实验研究[J].中国临床保健杂志, 2018, 21(3):377. doi: 10.3969/J.issn.1672－6790.2018.03.024
[9] CAO Y, HUANG X, FAN Y, et al.Protective effect of triptolide against glomerular mesangial cell proliferation and glomerular fibrosis in rats involves the TGF-β1/Smad signaling pathway[J].Evid Based Complement Alternat Med, 2015, 2015:814089.
[10] SCHRODER K, TSCHOPP J.The inflammasomes[J].Cell, 2010, 140(6):821. doi: 10.1016/j.cell.2010.01.040
[11] LORENZ G, DARISIPUDI MN, ANDERS HJ.Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis[J].Nephrol Dial Transplant, 2014, 29(1):41. doi: 10.1093/ndt/gft332
[12] SHI B, NI Z, CAO L, et al.Serum IL-18 is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA nephropathy[J].Mediators Inflamm, 2012:728417.
[13] HAHN WH, CHO BS, KIM SD, et al.Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy[J].Pediatric Nephrol, 2009, 24(7):1329. doi: 10.1007/s00467-009-1146-5
[14] KATZIR Z, LEIBOVITCH E, Vaknin H, et al.Effect of atorvastatin on IgA nephropathy in the rat[J].Clin Nephrol, 2013, 79(3):214. doi: 10.5414/CN107621
[15] TIAN J, WANG Y, GUO H, et al.The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option[J].Exp Mol Pathol, 2015, 99(3):435. doi: 10.1016/j.yexmp.2015.08.004
[16] HAN F, WANG S, CHANG Y, et al.Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway[J].J Cell Physiol, 2017, 233(3):2225.
[17] XUE M, CHENG Y, HAN F, et al.Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease[J].Int J Biol Sci, 2018, 14(11):1545. doi: 10.7150/ijbs.24032
[18] KAMEI K, OGURA M, SATO M, et al.Evolution of IgA nephropathy into anaphylactoid purpura in six cases——further evidence that IgA nephropathy and Henoch-Schonlein purpura nephritis share common pathogenesis[J].Pediatr Nephrol, 2016, 31(5):779. doi: 10.1007/s00467-015-3290-4
[19] SHIBANO T, TAKAGI N, MAEKAWA K, et al.Epidemiological survey and clinical investigation of pediatric IgA nephropathy[J].Clin Exp Nephrol, 2016, 20(1):111. doi: 10.1007/s10157-015-1129-8
[20] 王骞, 叶紫, 徐蝶衣, 等.滋阴凉血汤对IgA肾病大鼠的肾脏保护机制研究[J].广州中医药大学学报, 2018, 35(4):672.
[21] 杨南, 郭登洲.活血通络清热利湿方对IgA肾病大鼠肾组织IL-13、IL-4 mRNA及血清CIC的影响[J].中华中医药杂志, 2018, 33(7):2820.
[22] 潘立军, 詹继红, 蔡青.补肾调肝化瘀法治疗气阴两虚型IgA肾病临床观察[J].中华中医药学刊, 2017, 35(12):3131.
[23] YANG L, WANG Y, NUERBIVE A, et al.Effects of periostracum cicadae on cytokines and apoptosis regulatory proteins in an IgA nephropathy rat model[J].Int J Mol Sci, 2018, 19(6):1599. doi: 10.3390/ijms19061599
[24] YANG Q, SUN M, CHEN Y, et al.Triptolide protects podocytes from TGF-β-induced injury by preventing miR-30 downregulation[J].Am J Transl Res, 2017, 9(11):5150.
[25] 梁倩.IgA肾病患者外周血单个核细胞活化与凋亡及雷公藤甲素干预研究[D].长沙: 中南大学, 2009.
[26] GUO C, LI Y, ZHANG R, et al.Protective effect of salidroside against diabetic kidney disease through inhibiting BIM-Mediated apoptosis of proximal renal tubular cells in rats[J].Front Pharmacol, 2018, 9:1433. doi: 10.3389/fphar.2018.01433
[27] 王天然, 邹自英, 李继红, 等.槲皮素干预实验性慢性肾衰大鼠尿量与尿蛋白量动态变化[J].中国现代应用药学, 2012, 29(1):8.
[28] 耿嘉, 白妍, 张雪枫, 等.清心莲子丸治疗IgA肾病的疗效观察及其对血清IFN-γ、IL-4水平的影响[J].中国中医药科技, 2018, 25(3):319.
[29] NOGAKI F, MUSO E, KOBAYASHI I, et al.Interleukin12 induces crescentic glomerular lesions in a high IgA strain of ddY mice, independently of changes in IgA deposition[J].Nephrol Dial Transplant, 2000, 15(8):1146. doi: 10.1093/ndt/15.8.1146
[30] STANGOU M, BANTIS C, SKOULAROPOULOU M, et al.Th1, Th2 and Treg/T17 cytokines in two types of proliferative glomerulonephritis[J].Indian J Nephrol, 2016, 26(3):159. doi: 10.4103/0971-4065.159303
[31] TSAI YL, HHUA KF, CHEN A, et al.NLRP3 inflammasome:Pathogenic role and potential therapeutic target for IgA nephropathy[J].Sci Rep, 2017(7):41123.
[32] ZHANG L, WANG XZ, LI YS, et al.Icariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway[J].FEBS Open Bio, 2017, 7(1):54. doi: 10.1002/2211-5463.12161
[33] CHANG YP, KA SM, HSU WH, et al.Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy[J].J Cell Physiol, 2015, 230(7):1567. doi: 10.1002/jcp.24903